Akero Therapeutics, Inc. (AKRO)

Dec 9, 2025 - AKRO was delisted (reason: acquired by NVO)

54.65

0.00 (0.00%)

Inactive · Last trade price on Dec 8, 2025

Akero Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-292.82	-252.06	-151.76	-112.03	-100.78	-79.21
Depreciation & Amortization	0.02	0.02	0.03	0.04	0.04	0.02
Other Amortization	0.72	0.61	0.79	0.2	-	-
Asset Writedown & Restructuring Costs	-	1	-	-	-	-
Loss (Gain) From Sale of Investments	-10.76	-13.12	-9.55	-0.01	1.07	0.08
Stock-Based Compensation	34.28	29.7	21.5	23.24	10.05	6.02
Other Operating Activities	1.54	0.75	0.31	0.5	0.21	0.2
Change in Accounts Payable	-4.73	2.01	-0.65	0.97	3.27	2.48
Change in Other Net Operating Assets	21.6	0.99	-6.03	-5.43	6.45	-0.4
Operating Cash Flow	-250.17	-230.11	-145.37	-92.52	-79.68	-70.8
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Capital Expenditures	-	-1	-	-	-	-0.15
Investment in Securities	-330.79	-108.71	-223.62	-63.83	42.28	-9.61
Investing Cash Flow	-330.79	-109.71	-223.62	-63.83	42.28	-9.76

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Long-Term Debt Issued	-	10	15	10	-	-
Net Debt Issued (Repaid)	-37.4	10	15	10	-	-
Issuance of Common Stock	478.93	436.69	339.09	246.5	1.12	203.96
Other Financing Activities	-0.61	-0.84	-0.78	-0.86	-0.52	-0.85
Financing Cash Flow	440.93	445.85	353.32	255.63	0.6	203.11

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Cash Flow	-140.03	106.03	-15.67	99.29	-36.8	122.54

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Free Cash Flow	-250.17	-231.11	-145.37	-92.52	-79.68	-70.95
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-3.20	-3.44	-2.77	-2.37	-2.29	-2.25
Levered Free Cash Flow	-156.88	-148.48	-94.05	-53.51	-43.22	-41.98
Unlevered Free Cash Flow	-154.71	-146.17	-92.56	-53.25	-43.22	-41.98

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash Interest Paid	4.25	3.98	2.48	0.44	-	-
Change in Working Capital	16.87	3	-6.67	-4.46	9.73	2.09

SEC Filings: 10-K · 10-Q